SPDR S&P Biotech ETF
227 hedge funds and large institutions have $3.11B invested in SPDR S&P Biotech ETF in 2016 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 70 increasing their positions, 60 reducing their positions, and 20 closing their positions.
Holders
227
Holders Change
+26
Holders Change %
+12.94%
% of All Funds
6.07%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.16%
New
49
Increased
70
Reduced
60
Closed
20
Calls
$724M
Puts
$1.04B
Net Calls
-$319M
Net Calls Change
+$22.3M
Top Buyers
| 1 |
1
Citigroup
New York
|
$549M |
| 2 |
DCM
2
Discovery Capital Management
South Norwalk,
Connecticut
|
$99.4M |
| 3 |
3
Goldman Sachs
New York
|
$607M |
| 4 |
4
Barclays
London,
United Kingdom
|
$85M |
| 5 |
5
Morgan Stanley
New York
|
$307M |
